Jesus Corral
Impact in
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Oncology top 1%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
Papers in
- Oncology 28
- Cancer Immunotherapy and Biomarkers 9
- Colorectal Cancer Treatments and Studies 8
- Lung Cancer Research Studies 7
- Pancreatic and Hepatic Oncology Research 3
-
- Lung Cancer Treatments and Mutations 24
- Lung Cancer Diagnosis and Treatment 7
- Gastric Cancer Management and Outcomes 4
- Co-authors
- Luis G Paz-Ares (13 shared papers)K. Nakagawa (8 shared papers)Yan Wu (7 shared papers)Tony S.K. Mok (9 shared papers)Adam Płużański (7 shared papers)R Cebolla Rosell (6 shared papers)Ki Hyeong Lee (6 shared papers)Maria Rita Migliorino (5 shared papers)
- Journals
- Annals of Oncology (9 papers)Clinical & Translational Oncology (5 papers)Journal of Thoracic Oncology (4 papers)Journal of Clinical Oncology (4 papers)Future Oncology (4 papers)
- Partner nations
- SpainUnited StatesItaly
In The Last Decade
Jesus Corral
51 papers receiving 3.5k citations
Jesus Corral's Hit Papers
Peers
Comparison fields: 5 of 106
- Pulmonary and Respiratory Medicine 2.2k
- Oncology 1.6k
- Cancer Research 355
- Molecular Biology 664
- Endocrinology, Diabetes and Metabolism 96
Countries citing papers authored by Jesus Corral
This map shows the geographic impact of Jesus Corral's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesus Corral with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesus Corral more than expected).
Fields of papers citing papers by Jesus Corral
This network shows the impact of papers produced by Jesus Corral. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesus Corral. The network helps show where Jesus Corral may publish in the future.
Co-authors
The 25 scholars most cited alongside Jesus Corral, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial Hit paper breakdown → | 2017 | 938 |
| 2 | PARAMOUNT: Final Overall Survival Results of the Phase III Study of Maintenance Pemetrexed Versus Placebo Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer Hit paper breakdown → | 2013 | 481 |
| 3 | Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial Hit paper breakdown → | 2012 | 472 |
| 4 | Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer and EGFR-Activating Mutations Hit paper breakdown → | 2018 | 349 |
| 5 | 2013 | 121 | |
| 6 | 2017 | 105 | |
| 7 | 2012 | 98 | |
| 8 | 2020 | 91 | |
| 9 | 2020 | 73 | |
| 10 | 2016 | 71 | |
| 11 | 2011 | 69 | |
| 12 | 2014 | 57 | |
| 13 | 2018 | 54 | |
| 14 | 2018 | 53 | |
| 15 | 2012 | 47 | |
| 16 | 2012 | 46 | |
| 17 | 2015 | 43 | |
| 18 | 2019 | 38 | |
| 19 | 2021 | 37 | |
| 20 | 2020 | 37 |
About Jesus Corral
Jesus Corral is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Biotechnology and Molecular Biology, having authored 53 papers that have together received 3.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (24 papers), Cancer Immunotherapy and Biomarkers (9 papers), Colorectal Cancer Treatments and Studies (8 papers), Lung Cancer Research Studies (7 papers), Lung Cancer Diagnosis and Treatment (7 papers), Cancer Genomics and Diagnostics (4 papers), Gastric Cancer Management and Outcomes (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.2k citations), Oncology (1.6k citations), Cancer Research (355 citations), Molecular Biology (664 citations) and Endocrinology, Diabetes and Metabolism (96 citations). Jesus Corral has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Luis G Paz-Ares, K. Nakagawa, Yan Wu, Tony S.K. Mok, Adam Płużański, R Cebolla Rosell, Ki Hyeong Lee, Maria Rita Migliorino, Seiji Niho and Ying Cheng. Their work appears in journals such as Annals of Oncology, Clinical & Translational Oncology, Journal of Thoracic Oncology, Journal of Clinical Oncology and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.